使用短期或长期免疫预防措施的 HBsAg 阳性患者原位肝移植后的结果 - Suppr | 超能文献

Outcome following orthotopic liver transplantation in HBsAg-positive patients using short- or long-term immunoprophylaxis.

作者信息

Lemmens H P, Langrehr J M, Blumhardt G, Lohmann R, Knoop M, Verschl J, Schattenfroh N, Neuhaus R, Hopf U, Bechstein W O

机构信息

Department of Surgery, University Hospital Rudolf Virchow, Free University of Berlin, Germany.

出版信息

Transplant Proc. 1994 Dec;26(6):3622-3.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Outcome following orthotopic liver transplantation in HBsAg-positive patients using short- or long-term immunoprophylaxis.使用短期或长期免疫预防措施的 HBsAg 阳性患者原位肝移植后的结果

Transplant Proc. 1994 Dec;26(6):3622-3.

2

Liver transplantation in hepatitis B surface antigen positive patients with postoperative long-term immunoprophylaxis.乙肝表面抗原阳性患者肝移植术后的长期免疫预防

Transplant Proc. 1995 Feb;27(1):1215-6.

3

Chronic rejection after orthotopic liver transplantation is increased under induction therapy with interleukin-2 receptor antibody BT563.在使用白细胞介素-2受体抗体BT563进行诱导治疗的情况下，原位肝移植后的慢性排斥反应会增加。

Transplant Proc. 2001 May;33(3):2290-1. doi: 10.1016/s0041-1345(01)01993-5.

4

Optimal clinical regimens for living related liver transplantation.

Transplant Proc. 1994 Oct;26(5):2665-8.

5

Incidence and impact of acute rejection episodes on short- and long-term graft survival in recipients of simultaneous pancreas-kidney transplantation.急性排斥反应事件对同期胰肾联合移植受者短期和长期移植物存活的发生率及影响

Transplant Proc. 1995 Feb;27(1):1319.

6

Interleukin-2 receptor antibody versus antithymocyte globulin as part of quadruple induction therapy after orthotopic liver transplantation: a randomized study.

Transplant Proc. 1996 Dec;28(6):3204.

7

Quadruple induction immunosuppression after liver transplantation with IL-2 receptor antibody (BT 563) is equally effective and better tolerated than ATG induction therapy.肝移植后使用白细胞介素-2受体抗体（BT 563）进行四联诱导免疫抑制与抗胸腺细胞球蛋白诱导治疗同样有效且耐受性更好。

Transplant Proc. 1993 Feb;25(1 Pt 1):587-9.

8

Interleukin-2 receptor antibody vs ATG for induction immunosuppression after liver transplantation: initial results of a prospective randomized trial.肝移植后白细胞介素-2受体抗体与抗胸腺细胞球蛋白用于诱导免疫抑制：一项前瞻性随机试验的初步结果

Transplant Proc. 1995 Feb;27(1):1140-1.

9

Incidence and outcome of chronic rejection in CyA- and FK 506-treated patients.接受环孢素A和他克莫司治疗的患者中慢性排斥反应的发生率及结果。

Transplant Proc. 1996 Dec;28(6):3183-4.

10

Increased rejection after liver transplantation in FK 506-treated patients is associated with viral hepatitis C disease.接受FK 506治疗的患者肝移植后排斥反应增加与丙型病毒性肝炎有关。

Transplant Proc. 1994 Dec;26(6):3637-9.

引用本文的文献

1

What have we learned about primary liver transplantation under tacrolimus immunosuppression? Long-term follow-up of the first 1000 patients.关于在他克莫司免疫抑制下进行的原位肝移植，我们了解到了什么？对首批1000例患者的长期随访。

Ann Surg. 1999 Sep;230(3):441-8; discussion 448-9. doi: 10.1097/00000658-199909000-00016.